Objective:To evaluate the clinical effectiveness of self-blood acupoint injection in the treatment of chronic obstructive pulmonary disease(COPD).Methods:Databases such as China Knowledge and Pubmed were searched to retrieve studies on the clinical randomized controlled trials of treating COPD by self-blood acupoint injections from the establishment of the databases to October 8,2023.Two researchers severally screened the literature,extracted the data,and assessed the risk of bias for the selected ones,and then performed a Meta-analysis by RevMan 5.4.Results:A total of 22 studies with 1 881 patients were included in the study,and the results of the Meta-analysis showed that compared with the control group,self-blood acupoint injection increased the total clinical efficiency[OR=3.73,95％CI(2.79,4.98),P＜0.000 01]and prolonged 6 WMT distances[MD=34.21,95％CI(24.92,43.51),P＜0.000 01],ameliorated CAT score[MD=-3.86,95％CI(-5.20,-1.26),P＜0.000 01],and improved lung function indexes such as FVC[MD=0.45,95％CI(0.42,0.49),P＜0.000 01],a total of 19 outcome indexes,and the differences were statistically significant between groups.Conclusions:Self-blood acupoint injection in the treatment of COPD can significantly improve 6 WMT distances,decrease TCM syndrome scores,SGRQ score and CAT score,improve the lung function,reduce the inflammatory index levels,and improve the immune function and the quality of life of the patients.
维普
万方数据